• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Improving Cognitive Screening Accuracy and Efficiency II: Application for Parkinsons disease (P6.307)
Conclusions:We demonstrate rapid, precise measurement of motor and cognitive components in PD that affords high classification accuracy in individuals performing in the normal range on the MMSE, offering an opportunity for sensitive, efficient cognitive monitoring.Disclosure: Dr. Davis has received personal compensation for activities with Digital Cognition Technologies, Inc. Dr. Davis has received royalty payments from Digital Cognition Technologies, Inc. Dr. Davis holds stock and/or stock options in Digital Cognition Technologies, Inc. Dr. Davis has received research support from Foxconn Corp. Dr. Souillard-Mandar has re...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Davis, R., Souillard-Mandar, W., Au, R., Penney, D. Tags: Behavioral and Cognitive Neurology: Diagnostic Testing Source Type: research

Mild Parkinsonian Signs Are a Risk Factor for Falls (P3.084)
CONCLUSIONS: MPS is a significant risk factor for falls. Early detection of this risk factor state is important in order to implement early fall prevention programs among primary care patients.Study Supported by: NIH/NIA K23AG034236Disclosure: Dr. Dahodwala has received research support from Teva Neuroscience. Dr. Nwadiogbu has nothing to disclose. Dr. Fitts has nothing to disclose. Dr. Partridge has nothing to disclose. Dr. Karlawish has received personal compensation in an editorial capacity for the Journal of the American Geriatrics Society. Dr. Karlawish has received license fee payments.
Source: Neurology - April 9, 2014 Category: Neurology Authors: Dahodwala, N., Nwadiogbu, C., Fitts, W., Partridge, H., Karlawish, J. Tags: Movement Disorders: Other Parkinsonian Disorders Source Type: research

Plasma Long Chain Fatty Acids and Cognition in Parkinson's Disease (P4.048)
CONCLUSIONS: 1) Lipid status may influence cognitive function in Parkinson's disease. 2) Principal components analysis may be a useful exploratory analysis for high-dimensional datasets like fatty acid profiles.Study Supported by:Pacific Northwest Udall Center (P50NS062684), Dept of Veteran's Affairs Northwest PADRECC, the Huber FamilyDisclosure: Dr. Murchison has received research support from National Institute for Neurological Disorders and Stroke. Dr. Quinn has received personal compensation for activities with Novartis as a speaker. Dr. Quinn has received research support from Elan Corp., Baxter Laboratories, Bristol-...
Source: Neurology - April 9, 2014 Category: Neurology Authors: Murchison, C., Quinn, J., Cholerton, B., Leverenz, J., Montine, T., Zabetian, C., Chung, K., Peterson, A., Bowman, G. Tags: Movement Disorders: Parkinson ' s Disease Biomarkers Source Type: research